×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
MP05-03: Small non-coding microRNAs (miRNAs) target hepatoma-derived growth factor (HDGF) as a novel therapeutic strategy for urothelial carcinoma
2021-05-24
MP05-02: PR-619, an inhibitor of deubiquitylating enzymes, reverses drug resistance in cisplatin-resistant urothelial carcinoma cells via suppression of c-myc
2021-05-24
MP05-01: The prognostic impact of tumour architecture for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
2021-05-24
MP04-10: Strangulated urethral prolapse occurring in a patient being treated for central precocious puberty
2021-05-24
MP04-09: The role of PRP injection in the prophylaxis of recurrent UTI in women-any predictive factor?
2021-05-24
MP04-08: The effect of uric acid on the calcium oxalate crystallization
2021-05-24
MP04-07: Obesity-related indices and its association with kidney stone
2021-05-24
MP04-06: The association between phthalate levels in urine and urinary uric acid
2021-05-24
MP04-05: The alteration of urinary protein after SWL in the patients with nephrolithiasis
2021-05-24
MP04-04: Thep tubeless percutaneous nephrolithotomy (pcnl) : the experience of Taichung Tzu Chi Hospital
2021-05-24
MP04-03: Fluoroless retroperitoneoscopic ureterolithotomy with simultaneous retrograde intrarenal surgery for renal stone extraction in the Galdakao-modified supine Valdivia position
2021-05-24
MP04-02: Retrograde intrarenal surgery for renal stone: initial experience
2021-05-24
MP04-01: High urinary crystal volume suggests hypercalciuria in the calcium stone formers
2021-05-24
MP03-10: Overexpression of Src is associated with worse prognosis and harbored the potential as a therapeutic target in urothelial carcinoma
2021-05-24
MP03-09: Effect of nephroureterectomy on circulating tumor cells in patients with upper urinary tract urothelial carcinoma
2021-05-24
MP03-08: Suppression of bone metastatic castration-resistant prostate cancer cell growth by a suicide gene delivered by JC polyomavirus-like particles
2021-05-24
MP03-07: Association risk of smoking on overall and specific mortality of patients with bladder cancer: A population-based study
2021-05-24
MP03-06: Intravesical instillation of azacitidine suppresses tumor formation through TNF-R1 and TRAIL-R2 signaling in genotoxic carcinogen–induced bladder cancer
2021-05-24
MP03-05: Overexpression of nucleobindin-2(NUCB2) in upper tract urothelial carcinoma
2021-05-24
MP03-04: Autophagy inhibitor increased-PD-L1 expression suppress the effect of antitumor immunity in bladder cancer
2021-05-24
MP03-03: Real world experience of metastatic urothelial carcinoma treated with immune check point inhibitors
2021-05-24
MP03-02: Synergistic effect of intravesical instillation of chidamide and mitomycin C treatment through Axl signaling in genotoxic carcinogen–induced bladder cancer
2021-05-24
MP03-01: Long term outcomes of endoscopic management of upper urinary tract urethelial carcinoma(UTUC) in Taiwan UTUC registry
2021-05-24
MP02-10: Does urinary tract infection impact the performance of fully automated urine chemistry analyzer uc-3500 in detecting albuminuria?
2021-05-24
<
36
37
38
39
40
41
42
43
44
45
>
/ 121